Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis
- PMID: 35778837
- PMCID: PMC9381911
- DOI: 10.1111/acel.13662
Urolithin A improves mitochondrial health, reduces cartilage degeneration, and alleviates pain in osteoarthritis
Abstract
Osteoarthritis (OA) is the most common age-related joint disorder with no effective therapy. According to the World Health Organization, OA affects over 500 million people and is characterized by degradation of cartilage and other joint tissues, severe pain, and impaired mobility. Mitochondrial dysfunction contributes to OA pathology. However, interventions to rescue mitochondrial defects in human OA are not available. Urolithin A (Mitopure) is a natural postbiotic compound that promotes mitophagy and mitochondrial function and beneficially impacts muscle health in preclinical models of aging and in elderly and middle-aged humans. Here, we showed that Urolithin A improved mitophagy and mitochondrial respiration in primary chondrocytes from joints of both healthy donors and OA patients. Furthermore, Urolithin A reduced disease progression in a mouse model of OA, decreasing cartilage degeneration, synovial inflammation, and pain. These improvements were associated with increased mitophagy and mitochondrial content, in joints of OA mice. These findings indicate that UA promotes joint mitochondrial health, alleviates OA pathology, and supports Urolithin A's potential to improve mobility with beneficial effects on structural damage in joints.
Keywords: Mitopure; chondrocytes; mitochondria; mitophagy; osteoarthritis; urolithin.
© 2022 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare the following competing interests: D.D., A.M.F, and C.R. are current employees and P.V. and P.A.A. were prior employees of Amazentis SA; C.R. is board member of Amazentis SA.
Figures
References
-
- Andreux, P. A. , Blanco‐Bose, W. , Ryu, D. , Burdet, F. , Ibberson, M. , Aebischer, P. , Auwerx, J. , Singh, A. , & Rinsch, C. (2019). The mitophagy activator urolithin a is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism, 1, 595–603. - PubMed
-
- Barbero, A. , Grogan, S. , Schäfer, D. , Heberer, M. , Mainil‐Varlet, P. , & Martin, I. (2004). Age related changes in human articular chondrocyte yield, proliferation and post‐expansion chondrogenic capacity. Osteoarthritis and Cartilage, 12, 476–484. - PubMed
-
- Blanco, F. J. , & Rego‐Pérez, I. (2020). Mitochondrial DNA in osteoarthritis disease. Clinical Rheumatology, 39, 3255–3259. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
